MENU
ATXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Astria Therapeutics (ATXS) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

ATXS is expected to report earnings to rise 1.90% to -42 cents per share on March 06

Astria Therapeutics ATXS Stock Earnings Reports
Q4'24
Est.
$-0.43
Q3'24
Est.
$-0.42
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.08
The last earnings report on November 13 showed earnings per share of -41 cents, meeting the estimate of -41 cents. With 95.90K shares outstanding, the current market capitalization sits at 599.80M.
View a ticker or compare two or three
ATXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 State Street
Phone
+1 617 349-1971
Employees
59
Web
https://www.astriatx.com